Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases. 

Life Sciences

Therapeutics

Sentynl Therapeutics, Inc.

Sentynl Therapeutics, Inc.'s headquarters in Solana Beach, United States

Matt Heck

Yvonne Breugelmans Mshrm

Jennifer Reese

Michael Hercz

Grant Castor

The Leadership Team at Sentynl Therapeutics, Inc. is responsible for setting the strategic direction of the company, ensuring regulatory compliance, spearheading commercial and medical initiatives, overseeing business development, and maintaining high standards of quality and operational efficiency. This team aims to drive the company's mission to deliver innovative therapies to patients with rare diseases.

Leadership Team

The Commercial Strategy and Operations team at Sentynl Therapeutics, Inc. formulates and executes strategic initiatives to drive market access and sales for innovative therapies targeting rare diseases. This team collaborates on market analysis, sales planning, account management, and program management to optimize commercial performance and support patient access to treatments.

Commercial Strategy and Operations

The Regulatory and Compliance team at Sentynl Therapeutics, Inc. ensures adherence to legal and industry standards by overseeing regulatory submissions, maintaining quality assurance, and developing compliance policies. This team plays a critical role in navigating the regulatory landscape to facilitate the approval and ongoing compliance of innovative therapies for rare diseases.

Sentynl Therapeutics, Inc.

Org chart

Teams

Leadership Team

Commercial Strategy and Operations

Regulatory and Compliance

Offices

Sentynl Therapeutics, Inc.

Org chart

Teams

Leadership Team

Commercial Strategy and Operations

Regulatory and Compliance

Offices

Related companies